CAPTRUST FINANCIAL ADVISORS - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,000
+100.0%
599
+103.1%
0.00%
Q1 2022$2,000
-80.0%
295
-79.9%
0.00%
Q4 2021$10,000
-9.1%
1,465
-30.8%
0.00%
Q3 2021$11,000
-15.4%
2,116
-5.1%
0.00%
Q2 2021$13,000
+30.0%
2,229
+5.3%
0.00%
Q1 2021$10,0002,116
+1566.1%
0.00%
Q4 2020$01270.0%0.00%
Q3 2020$01270.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 213,609$1,446,0002.75%
GABLES CAPITAL MANAGEMENT INC. 449,164$3,041,0001.81%
Prairiewood Capital, LLC 261,403$1,770,0001.40%
ARMISTICE CAPITAL, LLC 9,572,000$64,802,0001.06%
Quantedge Capital Pte Ltd 360,100$2,438,0001.03%
SummerHaven Investment Management, LLC 151,384$1,025,0000.55%
GLOBEFLEX CAPITAL L P 609,030$4,124,0000.42%
EAM Global Investors LLC 347,899$2,355,0000.42%
Lanham O'Dell & Company, Inc. 50,000$339,0000.27%
EAM Investors, LLC 239,071$1,619,0000.27%
View complete list of CATALYST PHARMACEUTICALS INC shareholders